By means of Langendor ff isolated-heart perfusion technique, a model of cardiac global hypoxia/reoxygenation was prepared. Breviscapin (100mg/L in perfusate) effectively reduced the myocardial hypoxic perfusion and reoxygenation damage with respect to lowering myocardial CPK release, indicating a membrane-protective effect of the drug. After 50min hypoxic perfusion. Breviscapin-treated grup showed relatively higher myocardial activity of superoxide dismutase and glutathione peroxidase comparing to the control group. After 5min reoxygenation, the level of myocardial malondialdehyde-like substance in the treated group was lower than that in the control group indicating less free radical accumulated in the myocardium of treated group.
展开▼
